Advertisement
UK markets closed
  • FTSE 100

    7,706.28
    +21.79 (+0.28%)
     
  • FTSE 250

    19,179.56
    -83.94 (-0.44%)
     
  • AIM

    747.77
    -2.19 (-0.29%)
     
  • GBP/EUR

    1.1707
    +0.0015 (+0.13%)
     
  • GBP/USD

    1.2673
    +0.0015 (+0.12%)
     
  • Bitcoin GBP

    40,677.43
    +466.39 (+1.16%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,088.80
    +1.77 (+0.03%)
     
  • DOW

    39,131.53
    +62.42 (+0.16%)
     
  • CRUDE OIL

    76.57
    -2.04 (-2.60%)
     
  • GOLD FUTURES

    2,045.80
    +15.10 (+0.74%)
     
  • NIKKEI 225

    39,098.68
    +836.48 (+2.19%)
     
  • HANG SENG

    16,725.86
    -17.09 (-0.10%)
     
  • DAX

    17,419.33
    +48.88 (+0.28%)
     
  • CAC 40

    7,966.68
    +55.08 (+0.70%)
     

Synthetic Cells Market Projected to Reach $7.2 Billion by 2030 with Pharmaceutical & Diagnostics Segment Driving Robust Growth

Company Logo
Company Logo

Global Market for Synthetic Cells

Global Market for Synthetic Cells
Global Market for Synthetic Cells

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Synthetic Cells - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

An in-depth analysis of the Synthetic Cells industry reveals a dynamic growth trajectory, with an anticipated global market expansion from US$1.5 Billion in 2022 to an impressive US$7.2 Billion by the year 2030. This robust growth represents a compound annual growth rate (CAGR) of 22% over the forecast period and underscores the significant technological advancements anticipated in the years to come.

Pharmaceutical & Diagnostics Segment to Spearhead Growth

Among the various application segments, Pharmaceuticals & Diagnostics stand out with a projected CAGR of 25%. This segment is anticipated to lead the charge in market expansion, reaching an estimated US$3.1 Billion by the end of the analysis period. The strong growth outlook for this segment can be attributed to increasing investments in research and development, as well as the rising demand for innovative diagnostic solutions and personalized medicine.

Emerging Markets Show Prominent Growth

While the U.S. Synthetic Cells market remains a significant contributor with a 2022 valuation of US$396.6 Million, China is forecasted to demonstrate exceptional growth at a CAGR of 30.1%, positioning it as a key player with a projected market size of US$2 Billion by 2030. This growth prospects place China at the forefront of expanding markets within the Synthetic Cells sphere. Other geographic regions such as Japan and Canada are also expected to exhibit notable CAGRs of 14.8% and 19.2%, respectively, over the same period. Germany is positioned for substantial growth within Europe, with an expected CAGR of around 17.2%.

Industry-wide Competitive Analysis

The analysis also presents a granular examination of competitive dynamics, including market presence across various geographies characterized as Strong, Active, Niche, or Trivial. A selection of 34 notable competitors is featured, highlighting the diverse and innovative landscape of companies driving forward the Synthetic Cells market.

Keeping Abreast with Industry Transformations

To ensure stakeholders are equipped with the latest insights, the report includes online interactive updates that foster peer-to-peer collaboration, as well as access to digital archives and the research platform. Stakeholders will also benefit from complimentary updates for one year, ensuring access to the most current industry data and trend analyses.

Looking Ahead

In conclusion, the unprecedented growth trajectory outlined in this comprehensive analysis illustrates the dynamic and evolving nature of the Synthetic Cells industry. As key market segments and regions continue to expand at a rapid pace, stakeholders are presented with a wealth of opportunities for investment and innovation within the global marketplace.

Key Attributes:

Report Attribute

Details

No. of Pages

89

Forecast Period

2022 - 2030

Estimated Market Value (USD) in 2022

$1.5 Billion

Forecasted Market Value (USD) by 2030

$7.2 Billion

Compound Annual Growth Rate

21.7%

Regions Covered

Global


A selection of companies mentioned in this report includes

  • Agilent Technologies, Inc.

  • Amyris, Inc.

  • GenScript Biotech Corporation

  • Ginkgo Bioworks

  • Intrexon Corporation

  • Merck KGaA

  • Novozymes A/S

  • Synthetic Genomics, Inc.

  • Thermo Fisher Scientific, Inc.

  • Twist Bioscience

For more information about this report visit https://www.researchandmarkets.com/r/2u41s2

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900